Vignola Mark J. 4
4 · Terns Pharmaceuticals, Inc. · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Vignola Mark J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-11-30$3.78/sh+743$2,809→ 18,399 total
Footnotes (1)
- [F1]Includes the purchase of 743 shares under the Terns Employee Stock Purchase Plan on November 30, 2023.